Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al.

CourtDistrict Court, C.D. California
DecidedJuly 19, 2024
Docket2:20-cv-03444
StatusUnknown

This text of Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al. (Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al., (C.D. Cal. 2024).

Opinion

1 O 2 3 4 5 6 7 8 9 UNITED STATES DISTRICT COURT 10 CENTRAL DISTRICT OF CALIFORNIA 11 Case No.: 2:20-cv-03444-MEMF-PVCx 12 SKYE ORTHOBIOLOGICS, LLC, et al.,

13 Plaintiffs, ORDER DENYING MOTION FOR PERMANENT INJUNCTION [ECF NO. 629] 14 v.

15 16 CTM BIOMEDICAL, LLC, et al., Defendants. 17 18

19 20 21 Before the Court is Plaintiffs’ Post-Trial Motion for Injunctive Relief. ECF No. 629. For the 22 reasons stated herein, the Court hereby DENIES the Motion. 23 24 25 26 27 / / / 28 / / / 1 I. Background 2 The Court has laid out the background for this case in prior orders and accordingly only 3 recites the factual and procedural history as relevant to this order herein. On August 21, 2023, trial 4 for this matter commenced before a jury, to which the jury found Defendant Bryan Banman liable to 5 Plaintiffs Skye Orthobiologics, LLC (“Skye”) and Human Regenerative Technologies, LLC 6 (“HRT”) for: (1) breaching his Consulting Agreement/Compensation Contract with HRT (Count 4), 7 with lost profits of $7,298,949; (2) breaching his April 18, 2018 Employment Agreement with Skye 8 (Count 5), with lost profits of $7,298,949; (3) breaching his April 18, 2018 Employment 9 Confidentiality Agreement with Skye (Count 5), with lost profits of $7,298,949; (4) breaching his 10 fiduciary duty to Skye (Count 10), with lost profits of $7,298,949 and punitive damages of 11 $12,780,000; and (5) breaching his duty of loyalty to Skye (Count 11), with lost profits of 12 $7,298,949 and punitive damages of $12,780,000. ECF No. 511 (“Verdict Form”). On September 13 21, 2023, the parties stipulated on a briefing schedule for post-trial motions. ECF No. 518. In 14 accordance with this stipulation, Banman filed his Rule 50 and 59 motions on October 16, 2023. 15 ECF Nos. 540, 544. On December 1, 2023, the Court entered judgment in this case.1 ECF No. 574. 16 On March 26, 2024, Plaintiffs filed the instant Motion for Permanent Injunction. ECF No. 17 629 (the “Motion”). On April 17, 2024, the Court issued an order granting in part Banman’s Rule 50 18 and 59 motions. ECF No. 633 (“Post-Trial Order”). In particular, the Court reversed the jury finding 19 on Count 5 as to the Skye Confidentiality Agreement only, and found insufficient evidence to 20 support the punitive damages.2 On May 10, 2024, Banman filed his opposition to the Motion. ECF 21 No. 639 (“Opposition”). On May 18, 2024, Plaintiffs filed their reply. ECF No. 648 (“Reply”). 22 II. Legal Standard 23 A plaintiff seeking a permanent injunction must demonstrate the following: (1) that it has 24 suffered an irreparable injury; (2) that remedies available at law, such as monetary damages, are 25

26 1 The Court issued the Judgment in this case on November 1, 2023, but due to a delay in docketing, the 27 Judgment did not appear on the docket until December 1, 2023. 2 The Court ordered the parties to submit further briefing regarding the appropriate remedy on a Rule 59 28 1 inadequate to compensate for that injury; (3) that, considering the balance of hardships between the 2 plaintiff and defendant, a remedy in equity is warranted; and (4) that the public interest would not be 3 disserved by a permanent injunction. eBay Inc. v. MercExchange, LLC, 547 U.S. 388, 391 (2006). 4 “The decision to grant or deny permanent injunctive relief is an act of equitable discretion by the 5 district court.” Id. 6 III. Discussion 7 Plaintiffs seek a permanent injunction to enjoin Banman along with his agents and his 8 companies (including CTM Biomedical, LLC) from manufacturing any products using HRT’s 9 confidential information. See ECF No. 629-5. For the reasons discussed herein, the Court finds that 10 the Motion itself is untimely brought and the relief sought was not only abandoned, but would 11 constitute double recovery by Plaintiffs.3 12 A. Plaintiffs’ Motion is Not Timely Brought 13 Although Plaintiffs cite no procedural basis for the bringing the Motion, they appear to 14 concede that it is essentially a motion brought under Rule 59(e) to amend the judgment in this case. 15 See Reply at 3; Classic Concepts, Inc. v. Linen Source, Inc., 716 F.3d 1282, 1285 (9th Cir. 2013) 16 (noting that “to the extent [the plaintiff] believed the Judgment was lacking, the appropriate vehicle 17 for relief was to file a motion to alter or amend” under the timeline pursuant to Rule 59, “not wait 18 nearly two months to bring the issue to the district court’s attention”). Such a motion “must be filed 19 no later than 28 days after the entry of the judgment. Fed. R. Civ. P. Rule 59(e).4 Here, there is no 20 dispute that Plaintiffs’ Motion is brought substantially after the 28-day deadline from the Court’s 21 22 23 24 3 Therefore, the Court need not reach the merits of whether a permanent injunction should issue. 4 The Ninth Circuit has previously held that a “district court has no discretion to consider a late [R]ule 59(e) 25 motion.” Carter v. U.S., 973 F.2d 1479, 1488 (9th Cir. 1992). However, the Court notes that other circuits have held the Rule 59(e) deadline not jurisdictional based on the Supreme Court’s subsequent rulings in 26 Bowles v. Russell, 551 U.S. 205 (2007) and Kontrick v. Ryan, 541 U.S. 443 (2004). See, e.g., Lizardo v. U.S., 619 F.3d 273 (3rd Cir. 2010) (holding that “Rule 59(e) can no longer be deemed a jurisdictional rule” post- 27 Bowles). The Ninth Circuit does not appear to have explicitly spoken on this issue, but the Court does not find it necessary to reach it. Here, regardless of whether the deadline is jurisdictional, there was no stipulation or 28 1 Judgment entered on December 1, 2023.5 Rather, Plaintiffs argue that “[a] substantial reduction of 2 the original judgment restarts the time to file a motion to alter or amend the judgment pursuant to 3 Rule 59(e).” Reply at 3. Plaintiffs rely solely on non-binding authority to support this point, and as 4 discussed next, the Court does not find that its Post-Trial Order restarted the timeline for Plaintiffs to 5 file the Motion here. 6 As an initial matter, the logic of Plaintiffs’ cited authority does not support its position. In the 7 Seventh Circuit case Plaintiffs rely on, the court specifically noted that “[t]he time limit would be a 8 joke if parties could continually file new motions, preventing the judgment from becoming final.” 9 Charles v. Daley, 799 F.2d 343, 347 (7th Cir. 1986). However, the Seventh Circuit explained that 10 “the purpose of Rule 59 is to allow the district court to correct its own errors, sparing the parties and 11 appellate courts the burden of unnecessary appellate proceedings.” Id. at 348. Therefore, “when a 12 court alters its judgment, a person aggrieved by the alteration may ask for a correction.” Id. 13 (emphasis in original); see also Lanard Toys Ltd. v. Novelty, Inc., 375 Fed. App’x. 705, 708 (9th Cir. 14 2010 (“When the district court substantively alters its original judgment in response to a Rule 59 15 motion, a second motion to amend, timely filed by a party aggrieved by substantive amendment to 16 the original judgment, will again toll the time to appeal.”) (emphasis added).6 Here, any alterations 17 to the judgment due to the issuance of the Post-Trial Order have no bearing on the relief sought by 18 Plaintiffs. It is also well-settled that a Rule 59(e) motion is not to be used to “relitigate old matters, 19 or to raise arguments or present evidence that could have been raised prior to the entry of judgment.” 20 21 22

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bowles v. Russell
551 U.S. 205 (Supreme Court, 2007)
Rockwell International Corp. v. United States
549 U.S. 457 (Supreme Court, 2007)
Exxon Shipping Co. v. Baker
128 S. Ct. 2605 (Supreme Court, 2008)
Lizardo v. United States
619 F.3d 273 (Third Circuit, 2010)
United States v. Campbell
268 F.3d 1 (First Circuit, 2001)
United States v. First National Bank of Circle
652 F.2d 882 (First Circuit, 1981)
Jay Carter Joan H. Carter v. United States
973 F.2d 1479 (Ninth Circuit, 1992)
Classic Concepts, Inc. v. Linen Source, Inc.
716 F.3d 1282 (Ninth Circuit, 2013)
Munden v. Ultra-Alaska Associates
849 F.2d 383 (Ninth Circuit, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
Skye Orthobiologics, LLC, et al. v. CTM Biomedical, LLC, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/skye-orthobiologics-llc-et-al-v-ctm-biomedical-llc-et-al-cacd-2024.